Monthly Archives: November 2014

Understanding how bacterial toxins target human cells will help develop new drugs

New drugs and treatment strategies will be developed from research that provides a new understanding of how bacterial toxins target human cells. …read more

By |November 27th, 2014|Uncategorized|0 Comments|

In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer

The bacterium Helicobacter pylori is strongly associated with gastric ulcers and cancer. …read more

By |November 27th, 2014|Uncategorized|0 Comments|

Experimental Ebola vaccine appears safe, prompts immune response

An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial. …read more

By |November 26th, 2014|Uncategorized|0 Comments|

Goodbye, needles: measles vaccine could be delivered with a puff of air

A new measles vaccine that takes the form of an easily administered inhalable dry powder has been proven safe in a human clinical trial. …read more

By |November 26th, 2014|Uncategorized|0 Comments|

Antibiotic to target staph infections, strep, comes from good bacteria in turkeys – another reason to be thankful

While the turkey you eat on Thursday will bring your stomach happiness and could probably kick-start an afternoon nap, it may also save your life one day. …read more

By |November 26th, 2014|Uncategorized|0 Comments|